Meropenem Qilu

Meropenem, the active ingredient in Meropenem Qilu, is a carbapenem presented as a sterile powder for reconstitution for intravenous use. It treats a range of serious bacterial infections in hospitalized patients, including intra‑abdominal, urinary tract, respiratory and bloodstream infections.

GNH USA supplies Meropenem Qilu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used for severe infections caused by Gram‑negative and Gram‑positive bacteria.

- Complicated intra‑abdominal infections: provides bacterial eradication in severe peritoneal infections. - Complicated urinary tract infections: treats resistant uropathogens in acute pyelonephritis and cystitis. - Nosocomial pneumonia: effective against hospital‑acquired respiratory infections, including ventilator‑associated pneumonia. - Septicemia: rapidly clears bloodstream infections caused by susceptible organisms. - Skin and soft tissue infections: manages deep or necrotizing infections caused by resistant bacteria.

Meropenem may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Diarrhea: mild to moderate loose stools. - Nausea: occasional feeling of queasiness. - Vomiting: occasional emesis. - Headache: transient mild headache. - Rash: mild skin erythema or pruritus. - Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with respiratory distress. - Seizures: especially in patients with renal impairment or CNS disease. - Clostridioides difficile colitis: severe intestinal inflammation. - Neutropenia: marked reduction in white blood cells. - Hepatotoxicity: significant liver injury. - Renal toxicity: acute kidney injury in susceptible individuals.

When using Meropenem, clinicians should consider patient‑specific factors and monitor for adverse events.

- Renal function: adjust dose in patients with impaired clearance. - CNS disorders: monitor for seizures, especially in those with pre‑existing epilepsy. - Pregnancy: category B, use only if benefit outweighs risk. - Lactation: caution, as drug is excreted in breast milk. - Allergies: avoid in patients with known carbapenem or β‑lactam hypersensitivity. - Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Valproic acid: increased risk of seizures due to reduced plasma levels. - Probenecid: may decrease renal clearance, raising drug concentrations.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxicity; monitor renal function. - Loop diuretics: potential for electrolyte disturbances; watch serum levels. - Anticoagulants (e.g., warfarin): possible alteration of INR; check coagulation parameters. - Oral contraceptives: may reduce effectiveness; advise alternative contraception.